4-Nitro-3-(trifluoromethyl)benzoic acid, 95.0%, 5g

MOCLOBEMIDE, 95%, 1g

(R)-2-(((Benzyloxy)carbonyl)amino)-4-phenylbutanoic acid, 95.0%, 250mg

N,N-dimethyl-4-(pyrazin-2-yl)aniline, 95.0%, 1g

VORAPAXAR, 95%, 250mg

(Benzo[b]thiophen-3-yl)acetic acid, 95.0%, 5g

1-Boc-2-methyl-piperidin-5-one, 98.0%, 500mg

(R)-2-((tert-Butoxycarbonyl)amino)-2-(thiophen-3-yl)acetic acid, 95.0%, 100mg

1-Fluoro-3-(2-methoxyethoxy)-2-nitrobenzene, 95.0%, 25g

(3-(3-Methoxy-3-oxopropyl)phenyl)boronic acid, 95.0%, 1g

ethyl 8-(3-methylphenyl)-8-oxooctanoate, 97.0%, 1g

4-BENZOYLMORPHOLINE, 95.0%, 5g

1,4-Thioxane>97.0%(GC)25g